Catalyst Wire Dossier Catalyst Wire Dossier

Isturisa

osilodrostat · Recordati Group
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Isturisa, covering 2020-03-06 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome [Phase 2]

See pricing